可吸收海藻酸盐支架持续释放转化生长因子β1增强兔模型肩袖愈合
研究用海藻酸盐支架持续释放TGF-β1,在48只兔双侧肩袖修复模型中分三组比较12周生物力学与组织学愈合质量。持续释放组极限失败载荷显著高于单纯修复组和单次注射组,改良Bonar总分也显著更高,但横截面积和极限应力无显著差异。
要点
- 海藻酸盐支架无细胞毒性,细胞增殖率为对照组的122.30%。
- 持续释放组极限失败载荷108.32±32.48 N,显著高于单纯修复组74.89±29.82 N和单次注射组80.02±34.42 N(P=.011)。
- 持续释放组改良Bonar总分7.50±1.31,显著高于单纯修复组5.00±1.54和单次注射组6.12±1.85(P=.001)。
核心结论
- 在兔肩袖修复后12周,采用海藻酸盐支架持续释放TGF-β1可改善生物力学和组织学结局。
研究设计与样本
- 对照实验室研究,48只兔行双侧冈上肌腱修复,分为3组,每组16只:单纯修复组、TGF-β1单次注射组、海藻酸盐支架持续释放TGF-β1组。
- 术前进行MTS法检测细胞增殖与代谢活性,并用酶联免疫吸附试验确认海藻酸盐支架持续释放TGF-β1的能力。
- 修复后12周进行生物力学和组织学分析以评估腱-骨愈合质量。
主要发现
- 海藻酸盐支架的细胞增殖率为对照(新鲜培养基)组的122.30%,确认无细胞毒性并增强细胞增殖;TGF-β1水平随海藻酸盐支架上的时间增加。
- 生物力学方面,持续释放组极限失败载荷为108.32±32.48 N,显著高于单纯修复组74.89±29.82 N和单次注射组80.02±34.42 N(P=.011);持续释放组中间实质撕裂较单纯修复组更常见(P=.028)。
- 冈上肌腱横截面积三组间无统计学差异(单纯修复组32.74±9.38;单次注射组33.76±8.89;持续释放组34.80±14.52;P=.882)。
- 极限应力三组间无统计学差异(单纯修复组2.62±1.13 MPa;单次注射组2.99±1.81 MPa;持续释放组3.62±2.24 MPa;P=.317)。
- 组织学上,持续释放组改良Bonar总分显著更高(单纯修复组5.00±1.54;单次注射组6.12±1.85;持续释放组7.50±1.31;P=.001);持续释放组腱-骨界面胶原方向、连续性和组织性更好,新生纤维软骨形成面积更明显。
临床怎么用
- 作者认为,海藻酸盐结合的生长因子递送系统可能改善人类肩袖修复后的愈合。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The failure rate for healing after rotator cuff repair is relatively high. PURPOSE: To establish a system for sustained release of transforming growth factor β1 (TGF-β1) using an alginate scaffold and evaluate the effects of the sustained release of TGF-β1 on rotator cuff healing in a rabbit model. STUDY DESIGN: Controlled laboratory study. METHODS: Before the in vivo animal study, a standard MTS assay was performed to evaluate cell proliferation and metabolic activity on the alginate scaffold. Additionally, an enzyme-linked immunosorbent assay was performed to confirm the capacity of the sustained release of TGF-β1-containing alginate scaffold. Once the in vitro studies were completed, bilateral supraspinatus tendon repairs were performed in 48 rabbits that were allocated to 3 groups (n = 16 each) (group 1, supraspinatus repair only; group 2, supraspinatus repair with TGF-β1 single injection; group 3, supraspinatus repair with TGF-β1 sustained release via an alginate-based delivery system). Biomechanical and histological analyses were performed to evaluate the quality of tendon-to-bone healing at 12 weeks after rotator cuff repair. RESULTS: The cell proliferation rate of the alginate scaffold was 122.30% compared with the control (fresh medium) group, which confirmed that the alginate sheet had no cytotoxicity and enhanced cell proliferation. Additionally, the level of TGF-β1 was found to increase with time on the alginate scaffold. Biomechanically, group 3 exhibited a significantly heightened ultimate failure load compared with groups 1 and 2 (group 1, 74.89 ± 29.82 N; group 2, 80.02 ± 34.42 N; group 3, 108.32 ± 32.48 N; P = .011) and more prevalent midsubstance tear compared with group 1 ( P = .028). However, no statistical differences were found in the cross-sectional area of the supraspinatus tendon (group 1, 32.74 ± 9.38; group 2, 33.76 ± 8.89; group 3, 34.80 ± 14.52; P = .882) and ultimate stress (group 1, 2.62 ± 1.13 MPa; group 2, 2.99 ± 1.81 MPa; group 3, 3.62 ± 2.24 MPa; P = .317). Histologically, group 3 exhibited a significantly heightened modified total Bonar score (group 1, 5.00 ± 1.54; group 2, 6.12 ± 1.85; group 3, 7.50 ± 1.31; P = .001). In addition, the tendon-to-bone interface for group 3 demonstrated better collagen orientation, continuity, and organization, and the area of new fibrocartilage formation was more evident in group 3. CONCLUSION: At 12 weeks after rotator cuff repair, the authors found improved biomechanical and histological outcomes for sustained release of TGF-β1 using alginate scaffold in a rabbit model. CLINICAL RELEVANCE: The alginate-bound growth factor delivery system might improve healing after rotator cuff repair in humans.
引用
- Yoon JP, Lee CH, Jung JW, et al. Sustained Delivery of Transforming Growth Factor β1 by Use of Absorbable Alginate Scaffold Enhances Rotator Cuff Healing in a Rabbit Model. Am J Sports Med. 2018. PMID: 29543511. doi:10.1177/0363546518757759
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。